Senior Programme Lead, Injectable Drug Delivery

Camwebdir; United Kingdom; À distance; GBP 85 000 - 110 000; Plein temps

Avantages offerts par ce poste

Annual profit-related bonus

Virtual shares

Employer pension contribution 10%

Private medical insurance

Life insurance

Enhanced parental leave and flexible返回

Electric car leasing

Cycle-to-work schemes

Season ticket loan

Local sports facilities and theatre

Résumé du poste

TTP Group, based at Melbourn near Cambridge, seeks a Programme Leader to drive injectable drug delivery device development from concept through transfer to manufacture. You will guide cross‑functional teams with a focus on technical excellence, regulatory alignment, and commercial impact.

You will lead strategic programmes, coach teams, and travel for in‑person client engagements to deliver transformative patient outcomes.

Qualifications

• Proven track record leading complex development programmes from concept to manufacture transfer.
• Deep engineering experience in medical device sector, especially injectable drug delivery device development.
• Strong fundamentals in mechanical and systems engineering; problem solving in ambiguity.

Responsabilités

• Lead large, high-volume development programmes from concept to transfer.
• Balance technical, regulatory, and commercial considerations to accelerate timelines.
• Coach multidisciplinary teams and ensure rigorous, collaborative delivery.

Connaissances

Programme leadership

Complex development management

Technical engineering depth

Systems engineering

Client relationship management

Travel to client meetings

Description du poste

TTP Group, based at Melbourn near Cambridge, seeks a Programme Leader to drive injectable drug delivery device development from concept through transfer to manufacture. You will guide cross‑functional teams with a focus on technical excellence, regulatory alignment, and commercial impact.

You will lead strategic programmes, coach teams, and travel for in‑person client engagements to deliver transformative patient outcomes.